Article ; Online: COVID-19: An overview for dermatologists.
International journal of dermatology
2020 Volume 59, Issue 12, Page(s) 1437–1449
Abstract: Numerous unexplained pneumonia cases were reported to the World Health Organization (WHO) by Wuhan, China, in December 2020. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a zoonotic pathogen, came into sight, spreading coronavirus disease ...
| Abstract | Numerous unexplained pneumonia cases were reported to the World Health Organization (WHO) by Wuhan, China, in December 2020. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a zoonotic pathogen, came into sight, spreading coronavirus disease 2019 (COVID-19) all over the globe. Association of cutaneous signs and symptoms with COVID-19 is being studied worldwide, principally, to determine if these dermatoses can help in early recognition of SARS-CoV-2 infection. These dermatological manifestations can range from erythematous rash, urticaria to livedo reticularis, and acrocyanosis in patients of all age groups. Correspondingly, dermatologists treating COVID-19 patients, suffering from inflammatory dermatoses, with biologics or immunomodulators should exert caution and use specific protocols to adjust the doses of these medications. Prevention of person-to-person transmission of COVID-19 is being promoted universally, with the use of personal protective equipment (PPE), hand washes, and hand sanitizers around the clock. However, an array of cutaneous adverse effects such as contact dermatitis, irritant contact dermatitis, friction blisters, contact urticaria, acne, and infections are associated with the use of PPE. Extra-pulmonary manifestations of COVID-19 are still emerging in the community, and physicians and researchers are working together globally to strengthen the clinical management of these patients. Cases of COVID-19 continue to rise across the world, and an unprecedented approach has been taken to develop effective vaccines and therapeutic strategies against existing and forthcoming mutagenic strains of SARS-CoV-2. |
|---|---|
| MeSH term(s) | Betacoronavirus/isolation & purification ; Betacoronavirus/pathogenicity ; COVID-19 ; Communicable Disease Control/instrumentation ; Communicable Disease Control/methods ; Communicable Disease Control/standards ; Coronavirus Infections/complications ; Coronavirus Infections/diagnosis ; Coronavirus Infections/epidemiology ; Coronavirus Infections/prevention & control ; Dermatitis, Contact/diagnosis ; Dermatitis, Contact/epidemiology ; Dermatitis, Contact/etiology ; Dermatology/standards ; Dermatology/trends ; Hand Hygiene/standards ; Humans ; Pandemics/prevention & control ; Personal Protective Equipment/adverse effects ; Personal Protective Equipment/standards ; Pneumonia, Viral/complications ; Pneumonia, Viral/diagnosis ; Pneumonia, Viral/epidemiology ; Pneumonia, Viral/prevention & control ; SARS-CoV-2 ; Skin Diseases, Infectious/diagnosis ; Skin Diseases, Infectious/epidemiology ; Skin Diseases, Infectious/virology |
| Keywords | covid19 |
| Language | English |
| Publishing date | 2020-10-27 |
| Publishing country | England |
| Document type | Journal Article ; Review |
| ZDB-ID | 412254-9 |
| ISSN | 1365-4632 ; 0011-9059 ; 1461-1244 |
| ISSN (online) | 1365-4632 |
| ISSN | 0011-9059 ; 1461-1244 |
| DOI | 10.1111/ijd.15257 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Ui VI Zs.189: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.